Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NEXUS

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 48
  • 0 comments

FDA approve CYCLOPHOSPHAMIDE

Comment Full text

CARNEGIE

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 55
  • 0 comments

FDA approve NITROFURANTOIN

Comment Full text

KINDOS

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 47
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text

TWI PHARMS

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 43
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

TG THERAPEUTICS, INC

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 43
  • 0 comments

FDA approve UBLITUXIMAB-XIIY

Comment Full text

SAGENT PHARMS

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 50
  • 0 comments

FDA approve HALOPERIDOL LACTATE

Comment Full text

SAGENT PHARMS

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 53
  • 0 comments

FDA approve HALOPERIDOL LACTATE

Comment Full text

AVET LIFESCIENCES

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 36
  • 0 comments

FDA approve MELPHALAN HYDROCHLORIDE

Comment Full text

PRINSTON PHARMA INC

  • FDA Approval
  • Oct. 30, 2024, 13:22 UTC
  • 45
  • 0 comments

FDA approve BRIVARACETAM

Comment Full text

MSN LABORATORIES PRIVATE LTD

  • FDA Approval
  • Oct. 30, 2024, 13:22 UTC
  • 42
  • 0 comments

FDA approve CABAZITAXEL

Comment Full text
  • Previous
  • 278
  • 279
  • 280
  • 281
  • 282
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2016)
  • SEC News(184759)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122443)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin